130 related articles for article (PubMed ID: 23921607)
1. Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease.
Ghezzi S; Galli L; Kajaste-Rudnitski A; Turrini F; Marelli S; Toniolo D; Casoli C; Riva A; Poli G; Castagna A; Vicenzi E
AIDS; 2013 Sep; 27(15):2335-44. PubMed ID: 23921607
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
3. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
[TBL] [Abstract][Full Text] [Related]
4. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
[TBL] [Abstract][Full Text] [Related]
5. Ancient and recent adaptive evolution in the antiviral TRIM22 gene: identification of a single-nucleotide polymorphism that impacts TRIM22 function.
Kelly JN; Woods MW; Xhiku S; Barr SD
Hum Mutat; 2014 Sep; 35(9):1072-81. PubMed ID: 24863734
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide scan in two groups of HIV-infected patients treated with dendritic cell-based immunotherapy.
Moura Rodrigues R; Plana M; Garcia F; Zupin L; Kuhn L; Crovella S
Immunol Res; 2016 Dec; 64(5-6):1207-1215. PubMed ID: 27704462
[TBL] [Abstract][Full Text] [Related]
7. TRIM22 genotype is not associated with markers of disease progression in children with HIV-1 infection.
Boswell MT; Yindom LM; Hameiri-Bowen D; McHugh G; Dauya E; Bandason T; Mujuru H; Esbjörnsson J; Ferrand RA; Rowland-Jones S
AIDS; 2021 Dec; 35(15):2445-2450. PubMed ID: 34870928
[TBL] [Abstract][Full Text] [Related]
8. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.
Vicenzi E; Poli G
Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252
[TBL] [Abstract][Full Text] [Related]
9. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
Singh R; Gaiha G; Werner L; McKim K; Mlisana K; Luban J; Walker BD; Karim SS; Brass AL; Ndung'u T;
J Virol; 2011 Jan; 85(1):208-16. PubMed ID: 20980524
[TBL] [Abstract][Full Text] [Related]
10. The interferon response inhibits HIV particle production by induction of TRIM22.
Barr SD; Smiley JR; Bushman FD
PLoS Pathog; 2008 Feb; 4(2):e1000007. PubMed ID: 18389079
[TBL] [Abstract][Full Text] [Related]
11. Association of a single nucleotide polymorphism in the ubxn6 gene with long-term non-progression phenotype in HIV-positive individuals.
Díez-Fuertes F; De La Torre-Tarazona HE; Calonge E; Pernas M; Bermejo M; García-Pérez J; Álvarez A; Capa L; García-García F; Saumoy M; Riera M; Boland-Auge A; López-Galíndez C; Lathrop M; Dopazo J; Sakuntabhai A; Alcamí J
Clin Microbiol Infect; 2020 Jan; 26(1):107-114. PubMed ID: 31158522
[TBL] [Abstract][Full Text] [Related]
12. Risk association of BST2 gene variants with disease progression in HIV-1 infected Indian cohort.
Gupte DS; Patil A; Selvaa Kumar C; Pandey S; Achrekar SK; Paranjape RS; Jagtap DD
Infect Genet Evol; 2020 Jun; 80():104139. PubMed ID: 31841700
[TBL] [Abstract][Full Text] [Related]
13. Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines.
Turrini F; Saliu F; Forlani G; Das AT; Van Lint C; Accolla RS; Berkhout B; Poli G; Vicenzi E
Virus Res; 2019 Aug; 269():197631. PubMed ID: 31136823
[TBL] [Abstract][Full Text] [Related]
14. DBP rs16846876 and rs12512631 polymorphisms are associated with progression to AIDS naïve HIV-infected patients: a retrospective study.
Jiménez-Sousa MÁ; Jiménez JL; Fernández-Rodríguez A; Bellón JM; Rodríguez C; Riera M; Portilla J; Castro Á; Muñoz-Fernández MÁ; Resino S
J Biomed Sci; 2019 Oct; 26(1):83. PubMed ID: 31640710
[TBL] [Abstract][Full Text] [Related]
15. Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C.
Sadeghi F; Bokharaei-Salim F; Salehi-Vaziri M; Monavari SH; Alavian SM; Salimi S; Vahabpour R; Keyvani H
J Med Virol; 2014 Sep; 86(9):1499-506. PubMed ID: 24889558
[TBL] [Abstract][Full Text] [Related]
16. Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator.
Yu S; Gao B; Duan Z; Xu W; Xiong S
Biochem Biophys Res Commun; 2011 Jul; 410(2):247-51. PubMed ID: 21651891
[TBL] [Abstract][Full Text] [Related]
17. TRIM22 inhibits respiratory syncytial virus replication by targeting JAK-STAT1/2 signaling.
Wang Y; Chen Y; Lin Y; Quan Y; Xiao X; Zhang R
J Med Virol; 2021 Jun; 93(6):3412-3419. PubMed ID: 32803897
[TBL] [Abstract][Full Text] [Related]
18. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
Gao B; Duan Z; Xu W; Xiong S
Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648
[TBL] [Abstract][Full Text] [Related]
19. Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.
Reddi TS; Merkl PE; Lim SY; Letvin NL; Knipe DM
PLoS Pathog; 2021 Feb; 17(2):e1009281. PubMed ID: 33524065
[TBL] [Abstract][Full Text] [Related]
20. Elevated rate of fixation of endogenous retroviral elements in Haplorhini TRIM5 and TRIM22 genomic sequences: impact on transcriptional regulation.
Diehl WE; Johnson WE; Hunter E
PLoS One; 2013; 8(3):e58532. PubMed ID: 23516500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]